Physician Assistant · Corbin, KY
NPI
1023445277
Since 2013
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2 Trillium Way, Suite 306
Corbin, KY, 40701
Phone (606) 526-4070
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
649 services
Medicare patients, 2024
125
Average age 76
Drug cost, 2024
$2.1M
4,529 prescriptions
Company payments, 2025
$340
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amanda M Brandon was code 99215 (office e&m - established), 343 times for 116 patients. In total Amanda M Brandon billed 649 services in 15 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 343 | 116 | $92.52 | $32K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 236 | 106 | $10.99 | $2,593 |
| 99214 Office E&M - Established | Facility | 29 | 24 | $58.17 | $1,687 |
By year: 2022 $27K for 330 services; 2023 $29K for 347 services; 2024 $38K for 649 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amanda M Brandon prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 666 prescriptions and refills. In total Amanda M Brandon wrote 4,529 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 666 | 1,052 | 150 | $659K |
| Jardiance Empagliflozin | 486 | 857 | 123 | $493K |
| Bumetanide Generic | 433 | 558 | 107 | $8,259 |
| Verquvo Vericiguat | 351 | 509 | 69 | $329K |
| Spironolactone Generic | 309 | 509 | 96 | $945 |
| Metoprolol Succinate Generic | 284 | 442 | 86 | $1,273 |
| Eliquis Apixaban | 228 | 349 | 55 | $200K |
| Farxiga Dapagliflozin Propanediol | 227 | 415 | 60 | $231K |
| Furosemide Generic | 187 | 290 | 80 | $402 |
| Carvedilol Generic | 137 | 235 | 43 | $562 |
| Atorvastatin Calcium Generic | 86 | 181 | 28 | $475 |
| Hydralazine Hcl Generic | 66 | 76 | 25 | $255 |
| Potassium Chloride Generic | 64 | 79 | 27 | $1,711 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 57 | 80 | 16 | $398 |
| Pantoprazole Sodium Generic | 56 | 86 | 19 | $451 |
Brand drugs: - claims; generic drugs: 2,332 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amanda M Brandon $340 ($340 in general payments such as food, travel and fees) from 8 companies. The largest payer was Merck Sharp & Dohme LLC with $113.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 7 | $113 |
| Pfizer Inc. PFE | 3 | $75.87 |
| Kestra Medical Technology Services, Inc. | 2 | $42.01 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $30.35 |
| Hologic Sales and Service, LLC HOLX | 1 | $23.1 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $18.79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18.39 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $18.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.